Evolution Media has put its weight behind MasterClass, an online education provider already backed by Bloomberg and Novel Group.

Tencent has led a $100m series D round for fantasy sports company Dream11, a deal that was first rumoured in April this year.

NIBC Bank has contributed to a $100m funding round for lender Acorn OakNorth, which is now valued at $2.3bn.

Guardant Health is targeting $100m in proceeds for its initial public offering on the Nasdaq Global Select Market, which would offer an exit to SoftBank.

Square-backed event ticketing management platform Eventbrite will price its shares between $19 and $21 and could raise up to a total of more than $241m when it goes public.

Boston Scientific will pay $500m upfront and up to $100m in milestone payments to acquire Augmenix, providing exits to Varian Medical Systems and Ascension Health.

Medison Ventures was among the participants in a round that will fund clinical tests for Alpha Tau's radiation-based cancer treatment.

Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline.

The Pfizer-backed cancer therapy developer has secured $120m in a convertible note offering led by Perceptive Advisors.